Trademarkia Logo

Australia

AU$
Trademark Search
IMMUNOSEQ DX

View On IPO.GOV.AU

IMMUNOSEQ DX
Cancelled: Cancelled at the request of IB

Last updated on 25 Oct 2022

Owner Info

Adaptive Biotechnologies Corporation

1551 Eastlake Avenue E,

Suite 200, UNITED STATES OF AMERICA

Serial Number

2083291 filed on 25 Sept 2019

Correspondent

Hoang-chi Truong Patent Law Works LLP

310 East 4500 South, Suite 400,

Salt Lake City UT 84107,

UNITED STATES OF AMERICA

IMMUNOSEQ DX

Classification Information

Class [005]
Medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection.

Class [042]
Medical laboratory services.

Class [044]
Medical services; providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and Read More

Mark Details

Serial Number

2083291

Registered On

25 Sept 2019

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

27 Mar 2019

Mark Type

US

Legal History

Show more

Status DateAction Taken
25th Oct 2022Status change to Voided
10th Nov 2020International Registration in Australia Protected correspondence sent
9th Nov 2020IP Right Registration Published
9th Nov 2020Status change to Registered/Protected
3rd Sept 2020Application Accepted correspondence sent
2th Sept 2020IP Right has been Examined
2th Sept 2020IP Right Acceptance Published
2th Sept 2020Status change to Accepted
23rd Apr 2020Awaiting examination
23rd Apr 2020Examination expedited